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Serious psychological distress (SPD) can adversely impact health and quality of life for people with 
atherosclerotic cardiovascular disease (ASCVD). The purpose of this study is to examine the association 
between SPD and the use of medical expenditure and utilization among people with and without ASCVD. 
A total of 18770 adults with ASCVD and 2083 adults without ASCVD as comparison group were 
identified from the population-based Medical Expenditure Panel Survey (2015). SPD was assessed using 
6-item Kessler Psychological Distress Scale. We examined the use of medical expenditure and utilization 
in ASCVD patients and comparison adults with/without SPD.  Two-part econometric models analyzed 
cost data. Multivariable logistic regression models were conducted for utilization adjusting for 
demographic and usual source of care covariates. Adjusted odds ratios and 95% confidence intervals were 
calculated. Prevalence of SPD was 9.91% in ASCVD patients compared to 3.51% in comparison adults. 
ASCVD patients with SPD have higher medical expenditure and utilization. Among people with ASCVD, 
the adjusted mean annual cost for those with and without SPD were $25,193.27 and $15,122.11. Among 
people without ASCVD, the adjusted mean annual cost for those with and without SPD were $10,975.11 
and $4,876.36. Better coordination of care and patient-physician discussions are likely needed to improve 




According to the American Heart Association, atherosclerotic cardiovascular disease (ASCVD) is not 
only the leading cause of mortality and morbidity in the United States, but it is also responsible for the 
highest health care costs for a single class of disease.1 The medical care that accompanies ASCVD often 
carries large per-capita medical expenditures, with an average annual out-of-pocket (OOP) spending of 
over $2,000, with almost one-half of direct expenditures being related to medication expenses. Even 
among those with health insurance, many people with ASCVD are inadequately protected from financial 
hardship due to the high costs of insurance, including deductible, copays, and coinsurances.2  
SPD (SPD) —— as a broad construct of depression, anxiety, panic, and existential fears —— are 
common experiences among ASCVD patients. A number of prospective studies have found that 
psychosocial factors such as depression, perceived stress, anger, and anxiety play a role in the 
development of cardiovascular disease (CVD).3 A study showed that SPD is associated with significant 
 
increases in total expenditures and most other categories of expenditure and utilization among adults. 
However, to author’s knowledge, there is no study to examine multiple categories of health expenditures 
and utilizations among individuals with ASCVD. In this report, we would examine the association 
between SPD and the receipt of healthcare expenditures and utilization among ASCVD patients. 
Individuals with SPD have been found to have increased expenditures and utilization across multiple 
categories of health services, including office visits, home health services, prescriptions, and emergency 
department (ED) visits. The prevention and management of SPD in patients free of established ASCVD 
represents an enormous opportunity for reducing healthcare cost and resource utilization nationwide.  
The Kessler six-item scale has been shown to be a valid and reliable measure of SPD (SPD) in 
community samples. In this study we aim to estimate the economic impact of a favorable CRF profile on 
healthcare expenditures and resource utilization (hospitalizations, prescription medication utilization, 





The Medical Expenditure Panel Survey (MEPS) data sets and codebooks used for this study are available 
to the public and can be accessed on the Agency for Healthcare Research and Quality website at: 
https://meps.ahrq.gov/mepsweb/. 5 We conducted a retrospective study that utilized data from the MEPS, 
2015. The MEPS, led by the Agency for Healthcare Research and Quality, is a set of largescale, national 
survey about individuals and families, their medical providers, and their employers. The Household 
Component of the MEPS collects data about health services used, their frequency and cost, charges, 
source of payment, income, employment, as well as ample data on insurance used by and available to US 
workers.5 The MEPS respondents are enrolled for 2 years of data collection, with a new panel beginning 
each year. The sampling frame for the MEPS Household Component is drawn from respondents to the 
National Health Interview Survey and the design of the MEPS Household Component survey includes 
sampling weights, stratification, and clustering. The MEPS sampling weights incorporate adjustment for 
the complex sample design and reflect survey nonresponse and population totals from the Current 
Population Survey.5 
In order to increase the study’s population, we used (from the MEPS Household Component) the full-year 
consolidated data files include most demographics on a person-level, while the medical conditions files 
include each diagnosis a person has, which after being transcribed verbatim at each survey, are translated 
into International Classification of Disease, 9th Edition, Clinical Modification (ICD-9-CM) by 
professional coders. MEPS also allows categorization by Clinical Classification Software, a tool from 
Healthcare Cost and Utilization Project that groups ICD-9-CM codes into meaningful clinical categories.6 
All files were linked together in order to determine accurate results for each individual. Since MEPS 
information is publicly available, de-identified data-files, it was exempt from institutional review board 
review.6 
Sample selection 
We limited our study population to US adults ≥ 18 years of age, who had a positive sampling weight, 




Individuals in the study population were classified into our outcome variables based on presence of either 
a prior diagnosis (ascertained by ICD-9-CM or Clinical Classification Software codes), or self-report for 
any of the following: ASCVD (coronary artery disease, cerebrovascular disease, or peripheral artery 
disease). 
Primary Independent variable 
MEPS uses a well-validated and widely used 6-question scale developed by Kessler et al (K6)5 to 
measure psychological distress. The K6 questions were asked at rounds 2 and 4 through the adult self-
administered questionnaire. The K6 includes questions regarding the frequency of 6 symptoms (feeling 
nervous, hopeless, restless or fidgety, so sad that nothing could cheer you up, that everything was an 
effort, and worthless) during the past 30 days. Five frequency options were given (none of the time, a 
little of the time, some of the time, most of the time, and all of the time) and scored on a scale of 0 to 4, 
respectively, such that the total score ranges from 0 to 24. SPD is defined as a score of ≥ 13 as 
recommended by Kessler et al. The K6 has been well validated in various populations and has 
demonstrated excellent internal consistency and reliability.7 
Outcome variables: expenditures and resource utilization 
Total annual direct medical expenditures were calculated for each person. Data for this variable included 
expenditures from all payer groups and out-of-pocket spending, including information from 
hospitalizations, prescribed medications, outpatient visits (hospital outpatient visits and office-based 
visits), emergency department (ED) visits, and other expenditures (dental visits, vision aid, home health 
care, and other medical supplies). In a similar fashion, resource utilization analysis assessed the total 
number of outpatient and ED visits, number of hospitalizations and number of prescription medications 
purchases/refills each surveyed individual incurred. All expenditures were adjusted to 2015 US dollars by 
use of the gross domestic product.8 
Other variables 
Other variables included in the study were age (grouped in 40-54, 55-64, 65-74, and ≥ 75), sex, family 
income (grouped in Poor/Near Poor [<125% of the 2012 federal poverty level], Low/Middle Income 
[125% to 400% federal poverty level], and High Income [≥ 400% federal poverty level]), race/ethnicity, 
employment, insurance type, education, geographical region and CRF profile. 
 
Statistical Analysis 
For comparison of demographic characteristics in our sample, χ2  tests were performed.8 Because of the 
right-skewedness of expenditures data (i.e. most expenditures are seen in only a small proportion of the 
population), 2-part models were utilized to study expenditures.9 Two-part models are often used to model 
healthcare expenditures, and are the product of (1) the probability that any given individual had any 
expenditures; and (2) their mean expenditures.10 The first part of the model consists of a probabilistic 
regression model (probit), which estimates the probability of zero versus positive expenditures. 
Contingent upon having a positive annual healthcare expenditure, a generalized linear model (glm) with 
gamma distribution and a logarithmic-link function estimates the average expenditure per capita10,11; we 
determined the distribution of the glm using the modified Park Test12. For resource utilization, unadjusted 
and adjusted logistic regression models were utilized. Unadjusted means and proportions were calculated, 
adjusting for the survey design and sampling weight. For all statistical analyses, P<0.05 was considered 
 
statistically significant. All analyses were carried out using Stata®, version 13.1 (StataCorp, LP, College 
Station, TX). Total and Marginal expenditures were estimated using the “margins” command after the 2-
part models.10 All analyses took into consideration the MEPS complex survey design. 
 
Results 
Population Characteristics  
The final study population consisted of 20,853 participants ≥ 18 years of age; demographic information 
is presented in Table 1. The weighted prevalence of SPD and its 95% confidence interval (95% CI) were 
4.09% (95% CI, 3.74%-4.46%) in all participants, 9.11% (95% CI, 7.55%-10.96%) in the subset of 
ASCVD patients, and 3.51% (95% CI, 3.20%-3.85%) in participants without ASCVD. Those with SPD 
were more likely to be older, poorer, female, have ASCVD, have poor CRF profile, and less educated.  
 
All ASCVD No ASCVD P 
Value  
SPD No SPD SPD No SPD SPD No SPD 
 
Sample 20853 2083 18770 
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Asian 42 (2.99) 1585 
(5.79) 
9 (3.71) 89 
(2.93) 
















Others 38 (3.90) 540 
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13 (5.95) 60 
(3.06) 




CRF profile, n 
(weighted %) 
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Employed in the 
last 12 months 
44 (4.06) 726 
(3.23) 
7 (2.94) 41 
(2.11) 
37 (4.39) 685 
(3.35) 
 
Unspecified 5 (0.47) 25 (0.14) 1 (0.29) 4 (0.07) 4 (0.52) 21 (0.15) 
 
Income as % of 
FPL 












































































































      
<0.001 
Uninsured 97 (8.94) 2720 
(9.11) 
20 (8.76) 110 
(4.03) 
77 (8.99) 2610 
(9.66) 
 



























Table 1: Baseline Characteristics From Adults ≥ 18 Years of Age, With and Without Cancer, From the 
MEPS Survey 2015 
 
Healthcare Expenditures 
Average per-capita healthcare expenditures estimated using univariate and multivariate models by SPD 
and ASCVD status are shown in Table 2. Presence of SPD was associated with increased overall 
healthcare expenditures compared with those without SPD across the spectrum of ASCVD status. 
ASCVD participants with SPD had a mean annual expenditure of $25 193 compared with $15 122 among 
those without SPD. Non-ASCVD participants with SPD had a mean annual expenditure of $10 975 
compared with $4 876 among those without SPD. 
Table 2. Total costs by ASCVD and SPD 
  ASCVD No ASCVD 
Model 1 
  
SPD $25004 (16142, 33867) $10639 (7860, 13419) 
No SPD $16176 (14622, 17729) $4576 (4290, 4861) 
Model 2 
  
SPD $25193 (15903, 34484) $10975 (8226, 13724) 
No SPD $15122 (12230, 18015) $4876 (4570, 5183) 




Figure. Mean per capita healthcare expenditures by ASCVD and SPD status. ASCVD indicates atherosclerotic cardiovascular 





Table 3 summarizes healthcare utilization rates across SPD and ASCVD status. Overall, the absence of 
SPD was associated with significantly less use of healthcare resources among individuals with and 
without ASCVD. Among participants with ASCVD, those with SPD were more likely to purchase/refill 
prescription medications (978%) or any hospitalization (71%). After adjusting for key covariates, among 
individuals with ASCVD, those with SPD had 1424% higher odds of purchasing/ refilling prescription 
medications (odds ratio, 15.24 [95% CI, 3.28-70.77]), 96% higher odds of being hospitalized (odds ratio, 
1.96 [95% CI, 1.34-2.88]), 110% higher odds of having an ED visit (odds ratio, 2.1 [95% CI, 1.39-3.16]), 
and 348% higher odds of having any outpatient visit (odds ratio, 4.48 [95% CI, 2.04-9.86]), compared 
with those without SPD.  
Table 3. Resource Utilization Stratified by ASCVD and SPD 
 
ASCVD No ASCVD 
Hospitalizations 
  
Proportion with any hospitalization 
 
SPD 0.33 0.13 
No SPD 0.22 0.06 
Average hospitalizations 
  
SPD 0.7 0.25 
No SPD 0.38 0.07 




Unadjusted 1.71 (1.20-2.45) 2.94 (2.16-4.01) 
Adjusted 1.96 (1.34-2.88) 2.29 (1.65-3.17) 
No SPD 
  
Unadjusted Ref Ref 
Adjusted Ref Ref 
ED 
  
Proportion with any ED visits 
 
SPD 0.5 0.33 
No SPD 0.3 0.13 
Average ED visits 
  
SPD 1.15 0.54 
No SPD 0.48 0.17 




Unadjusted 2.33 (1.56-3.49) 3.85 (3.19-4.65) 
Adjusted 2.1 (1.39-3.16) 3.11 (2.55-3.78) 
No SPD 
  
Unadjusted Ref Ref 




Proportion with any outpatient visits 
 
SPD 0.96 0.85 
No SPD 0.92 0.69 
Average outpatient visits 
  
SPD 0.44 0.57 
No SPD 0.6 0.2 




Unadjusted 2.84 (1.28-6.30) 2.67 (2.00-3.56) 
Adjusted 4.48 (2.04-9.86) 3.36 (2.48-4.56) 
No SPD 
  
Unadjusted Ref Ref 
Adjusted Ref Ref 
Prescription medications 
  
Proportion with any purchase/refills 
 
SPD 0.99 0.84 
No SPD 0.93 0.6 
Average purchase/refills 
  
SPD 59.42 28.26 
No SPD 37.09 10.19 




Unadjusted 10.78 (2.42-47.92) 3.72 (2.84-4.86) 
Adjusted 15.24 (3.28-70.77) 4.23 (3.15-5.67) 
No SPD 
  
Unadjusted Ref Ref 
Adjusted Ref Ref 
Table 3: Odds ratios are presented as: OR (95% CI). ASCVD indicates atherosclerotic cardiovascular disease; CI, confidence 
interval; CRF, cardiovascular risk factor; ED, emergency department; OR, odds ratio. 
*Adjusted for age, sex, socioeconomic status, race/ethnicity, insurance type, geographical region. 
 
Discussion  
Previous studies have evaluated the financial burden associated with ASCVD; however, to the authors’ 
knowledge, this is the first attempt to contextualize the economic impact of SPD in a contemporary 
national representative sample of the US population. We found a higher prevalence of ASCVD (9.11% 
VS 3.51%) among ASCVD patients compared with those without ASCVD. We found significantly 
reduced healthcare utilization and expenditures among ASCVD patients without SPD. 
Our results are consistent with prior reports highlighting the increased burden of distress in ASCVD 
patients. Several contributing factors to this observation include common risk factors, rapidly growing 
survivorship population with the majority over the age of 65. In our analysis, adults with SPD visited 
doctors more frequently. While our data do not allow us to examine the reasons for the healthcare visits 
and content of patient-provider discussions, the greater numbers of healthcare visits observed in this 
 
subgroup could be a symptom of the SPD. For example, adults may somaticize depressive symptoms and 
seek clinical care for experiencing non-specific concerns without realizing the possibility of having 
clinical depression. Other studies of adults with SPD have similarly found distress as a motivating factor 
for seeking healthcare. 
Our cross-sectional study does not allow for causal inferences. However, SPD, stress, anxiety, and 
depression are arguably important to monitor given significant associations with inflammation and several 
metabolic diseases. Heart disease and diabetes have been likened to posttraumatic stress disorder in 
cancer patients. There is mounting evidence of “social isolation” and depression (potentially characteristic 
in person with SPD) as predictors of mortality similar to that of well-documented clinical factors. Though 
the International Agency for Research on Cancer notes that there is still some work to be done 
specifically on the role of stress in disease onset or progression, the association between psychological 
status and physical health in ASCVD patients is a priority issue. 
Study Limitations 
Our study has several limitations. First, our analysis relied on self-reported data and our findings are 
subject to measurement error (e.g. underreporting) and to recall bias. This bias may be stronger among 
older adults and could affect variables that determine SPD. Second, the prevalence of ASCVD in this 
study was lower than previous national estimates, in part because we excluded hypertension. Third, lack 
of information on dietary habits did not allow us to include this important modifiable risk factor. 
Additionally, because of the lack of clinical factors (blood pressure, fasting blood glucose, and total 




In summary, we observed that SPD is associated with higher medical expenditures and utilization among 
people with and without ASCVD. For those experiencing high level psychological distress, we hope our 
work will produce evidence-based research to better inform policy makers and physicians to better 
address high levels of PSD corresponding higher medical expenditures, and to develop ways to decrease 
medical expenditures for this population. 
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